March 5, 2015

Starting HIV Medications Within First Weeks of Infection Decreases Hidden Virus

Clin Infect Dis. (2015) doi: 10.1093/cid/civ171First published online: March 3, 2015 Impact of the Earliness of Antiretroviral Therapy Initiation During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA Moussa […]
March 3, 2015

Most Important HIV Research Reports from CROI 2015

From Jules Levin: perhaps the biggest stories out of CROI from my perspective are the development of 2 new HIV therapies – the new attachment inhibitor & the new […]
January 30, 2015

Prezcobix and Evotaz: Two New HIV Fixed Dose Combinations Approved this Week

January 29, 2015 Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced the U.S. Food and Drug Administration (FDA) has approved PREZCOBIX™ (darunavir 800 mg/cobicistat […]
November 15, 2014

Cost Effectiveness of Current HIV Cure Approaches

Published: November 14, 2014 DOI: 10.1371/journal.pone.0113031 Abstract Background We examined efficacy, toxicity, relapse, cost, and quality-of-life thresholds of hypothetical HIV cure interventions that would make them […]